# Single DermaVir Immunization in HIV-1 Infected Patients on HAART

> **NCT00712530** · PHASE1 · COMPLETED · sponsor: **Genetic Immunity** · enrollment: 9 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **BIOLOGICAL:** DermaVir
- **DRUG:** HAART

## Key facts

- **NCT ID:** NCT00712530
- **Lead sponsor:** Genetic Immunity
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2013-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712530, "Single DermaVir Immunization in HIV-1 Infected Patients on HAART". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00712530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*